JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mukhopadhyay, A.
Right arrow Articles by Aggarwal, B. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mukhopadhyay, A.
Right arrow Articles by Aggarwal, B. B.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 274, Issue 23, 15978-15981, June 4, 1999

COMMUNICATION
Identification and Characterization of a Novel Cytokine, THANK, a TNF Homologue That Activates Apoptosis, Nuclear Factor-kappa B, and c-Jun NH2-Terminal Kinase

Asok Mukhopadhyay, Jian Ni§, Yifan Zhai§, Guo-Liang Yu§, and Bharat B. Aggarwal

From the Cytokine Research Laboratory, Department of Molecular Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030 and the § Human Genome Sciences, Inc., Rockville, Maryland 20850

By using the amino acid sequence motif of tumor necrosis factor (TNF), we searched the expressed sequence tag data base and identified a novel full-length cDNA encoding 285 amino acid residues and named it THANK. THANK is a type II transmembrane protein with 15-20% overall amino acid sequence homology to TNF, LT-alpha , FasL, and LIGHT, all members of the TNF family. The mRNA for THANK was expressed at high levels by peripheral blood leukocytes, lymph node, spleen, and thymus and at low levels by small intestine, pancreas, placenta, and lungs. THANK was also prominently expressed in hematopoietic cell lines. The recombinant purified protein expressed in the baculovirus system had an approximate molecular size 20 kDa with amino-terminal sequence of AVQGP. Treatment of human myeloid U937 cells with purified THANK activated nuclear transcription factor-kappa B (NF-kappa B) consisting of p50 and p65. Activation was time- and dose-dependent, beginning with as little as a 1 pM amount of the cytokines and as early as 15 min. Under the same conditions, THANK also activated c-jun NH2-terminal kinase (JNK) in U937 cells. THANK also strongly suppressed the growth of tumor cell lines and activated caspase-3. Although THANK had all the activities and potency of TNF, it did not bind to the TNF receptors. Thus our results indicate that THANK is a novel cytokine that belongs to the TNF family and activates apoptosis, NF-kappa B, and JNK through a distinct receptor.

Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Immunol.Home page
W. Stohl, N. Jacob, W. J. Quinn III, M. P. Cancro, H. Gao, C. Putterman, X. Gao, L. Pricop, and M. N. Koss
Global T Cell Dysregulation in Non-Autoimmune-Prone Mice Promotes Rapid Development of BAFF-Independent, Systemic Lupus Erythematosus-Like Autoimmunity
J. Immunol., July 1, 2008; 181(1): 833 - 841.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
G. Badr, G. Borhis, E. A. Lefevre, N. Chaoul, F. Deshayes, V. Dessirier, G. Lapree, A. Tsapis, and Y. Richard
BAFF enhances chemotaxis of primary human B cells: a particular synergy between BAFF and CXCL13 on memory B cells
Blood, March 1, 2008; 111(5): 2744 - 2754.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
M. C. Ryan, M. Hering, D. Peckham, C. F. McDonagh, L. Brown, K. M. Kim, D. L. Meyer, R. F. Zabinski, I. S. Grewal, and P. J. Carter
Antibody targeting of B-cell maturation antigen on malignant plasma cells
Mol. Cancer Ther., November 1, 2007; 6(11): 3009 - 3018.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
S. Morimoto, S. Nakano, T. Watanabe, Y. Tamayama, A. Mitsuo, Y. Nakiri, J. Suzuki, K. Nozawa, H. Amano, Y. Tokano, et al.
Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production
Rheumatology, July 1, 2007; 46(7): 1083 - 1086.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
R. Nimmanapalli, M.-A. Lyu, M. Du, M. J. Keating, M. G. Rosenblum, and V. Gandhi
The growth factor fusion construct containing B-lymphocyte stimulator (BLyS) and the toxin rGel induces apoptosis specifically in BAFF-R-positive CLL cells
Blood, March 15, 2007; 109(6): 2557 - 2564.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. O. Jacob, L. Pricop, C. Putterman, M. N. Koss, Y. Liu, M. Kollaros, S. A. Bixler, C. M. Ambrose, M. L. Scott, and W. Stohl
Paucity of Clinical Disease despite Serological Autoimmunity and Kidney Pathology in Lupus-Prone New Zealand Mixed 2328 Mice Deficient in BAFF
J. Immunol., August 15, 2006; 177(4): 2671 - 2680.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
K. Yoshimoto, Y. Takahashi, M. Ogasawara, Y. Setoyama, K. Suzuki, K. Tsuzaka, T. Abe, and T. Takeuchi
Aberrant expression of BAFF in T cells of systemic lupus erythematosus, which is recapitulated by a human T cell line, Loucy
Int. Immunol., July 1, 2006; 18(7): 1189 - 1196.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
W. G. Halpern, P. Lappin, T. Zanardi, W. Cai, M. Corcoran, J. Zhong, and K. P. Baker
Chronic Administration of Belimumab, a BLyS Antagonist, Decreases Tissue and Peripheral Blood B-Lymphocyte Populations in Cynomolgus Monkeys: Pharmacokinetic, Pharmacodynamic, and Toxicologic Effects
Toxicol. Sci., June 1, 2006; 91(2): 586 - 599.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. P. Miller, J. E. Stadanlick, and M. P. Cancro
Space, Selection, and Surveillance: Setting Boundaries with BLyS.
J. Immunol., June 1, 2006; 176(11): 6405 - 6410.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
L. Fu, Y.-C. Lin-Lee, L. V. Pham, A. Tamayo, L. Yoshimura, and R. J. Ford
Constitutive NF-{kappa}B and NFAT activation leads to stimulation of the BLyS survival pathway in aggressive B-cell lymphomas
Blood, June 1, 2006; 107(11): 4540 - 4548.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
D. Bischof, S. F. Elsawa, G. Mantchev, J. Yoon, G. E. Michels, A. Nilson, S. L. Sutor, J. L. Platt, S. M. Ansell, G. von Bulow, et al.
Selective activation of TACI by syndecan-2
Blood, April 15, 2006; 107(8): 3235 - 3242.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
A. J. Novak, D. M. Grote, S. C. Ziesmer, M. P. Kline, M. K. Manske, S. Slager, T. E. Witzig, T. Shanafelt, T. G. Call, N. E. Kay, et al.
Elevated Serum B-Lymphocyte Stimulator Levels in Patients With Familial Lymphoproliferative Disorders
J. Clin. Oncol., February 20, 2006; 24(6): 983 - 987.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
Y. Vugmeyster, D. Seshasayee, W. Chang, A. Storn, K. Howell, S. Sa, T. Nelson, F. Martin, I. Grewal, E. Gilkerson, et al.
A Soluble BAFF Antagonist, BR3-Fc, Decreases Peripheral Blood B Cells and Lymphoid Tissue Marginal Zone and Follicular B Cells in Cynomolgus Monkeys
Am. J. Pathol., February 1, 2006; 168(2): 476 - 489.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y. Zheng, S. Gallucci, J. P. Gaughan, J. A. Gross, and M. Monestier
A Role for B Cell-Activating Factor of the TNF Family in Chemically Induced Autoimmunity
J. Immunol., November 1, 2005; 175(9): 6163 - 6168.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
M Schaller, W Stohl, S M Tan, V M Benoit, D M Hilbert, and H J Ditzel
Raised levels of anti-glucose-6-phosphate isomerase IgG in serum and synovial fluid from patients with inflammatory arthritis
Ann Rheum Dis, May 1, 2005; 64(5): 743 - 749.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. Gatto, C. Ruedl, B. Odermatt, and M. F. Bachmann
Rapid Response of Marginal Zone B Cells to Viral Particles
J. Immunol., October 1, 2004; 173(7): 4308 - 4316.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
W Stohl, S Metyas, S-M Tan, G S Cheema, B Oamar, V Roschke, Y Wu, K P Baker, and D M Hilbert
Inverse association between circulating APRIL levels and serological and clinical disease activity in patients with systemic lupus erythematosus
Ann Rheum Dis, September 1, 2004; 63(9): 1096 - 1103.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Shulga-Morskaya, M. Dobles, M. E. Walsh, L. G. Ng, F. MacKay, S. P. Rao, S. L. Kalled, and M. L. Scott
B Cell-Activating Factor Belonging to the TNF Family Acts through Separate Receptors to Support B Cell Survival and T Cell-Independent Antibody Formation
J. Immunol., August 15, 2004; 173(4): 2331 - 2341.
[Abstract] [Full Text] [PDF]

Home page
 J BiochemHome page
G. Chen, S. Peng, M. Zou, H. Xu, D. Xu, and J. Wang
Construction and Function of Two Cys146-Mutants with High Activity, Derived from Recombinant Human Soluble B Lymphocyte Stimulator
J. Biochem., July 1, 2004; 136(1): 73 - 79.
[Abstract] [Full Text] [PDF]

Home page
 LupusHome page
W Stohl
A therapeutic role for BLyS antagonists
Lupus, May 1, 2004; 13(5): 317 - 322.
[Abstract] [PDF]

Home page
 BloodHome page
J. Moreaux, E. Legouffe, E. Jourdan, P. Quittet, T. Reme, C. Lugagne, P. Moine, J.-F. Rossi, B. Klein, and K. Tarte
BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone
Blood, April 15, 2004; 103(8): 3148 - 3157.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
B. Huard, L. Arlettaz, C. Ambrose, V. Kindler, D. Mauri, E. Roosnek, J. Tschopp, P. Schneider, and L. E. French
BAFF production by antigen-presenting cells provides T cell co-stimulation
Int. Immunol., March 1, 2004; 16(3): 467 - 475.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
E. Varfolomeev, F. Kischkel, F. Martin, D. Seshasayee, H. Wang, D. Lawrence, C. Olsson, L. Tom, S. Erickson, D. French, et al.
APRIL-Deficient Mice Have Normal Immune System Development
Mol. Cell. Biol., February 1, 2004; 24(3): 997 - 1006.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
C. Kern, J.-F. Cornuel, C. Billard, R. Tang, D. Rouillard, V. Stenou, T. Defrance, F. Ajchenbaum-Cymbalista, P.-Y. Simonin, S. Feldblum, et al.
Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway
Blood, January 15, 2004; 103(2): 679 - 688.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. J. Novak, J. R. Darce, B. K. Arendt, B. Harder, K. Henderson, W. Kindsvogel, J. A. Gross, P. R. Greipp, and D. F. Jelinek
Expression of BCMA, TACI, and BAFF-R in multiple myeloma: a mechanism for growth and survival
Blood, January 15, 2004; 103(2): 689 - 694.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
K. Schneider, S. Kothlow, P. Schneider, A. Tardivel, T. Gobel, B. Kaspers, and P. Staeheli
Chicken BAFF--a highly conserved cytokine that mediates B cell survival
Int. Immunol., January 1, 2004; 16(1): 139 - 148.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
F Melchers
Actions of BAFF in B cell maturation and its effects on the development of autoimmune disease
Ann Rheum Dis, November 1, 2003; 62(90002): ii25 - 27.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
Z. SM. Rahman, S. P. Rao, S. L. Kalled, and T. Manser
Normal Induction but Attenuated Progression of Germinal Center Responses in BAFF and BAFF-R Signaling-Deficient Mice
J. Exp. Med., October 20, 2003; 198(8): 1157 - 1169.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
L. Gorelik, K. Gilbride, M. Dobles, S. L. Kalled, D. Zandman, and M. L. Scott
Normal B Cell Homeostasis Requires B Cell Activation Factor Production by Radiation-resistant Cells
J. Exp. Med., September 15, 2003; 198(6): 937 - 945.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Pelletier, J. S. Thompson, F. Qian, S. A. Bixler, D. Gong, T. Cachero, K. Gilbride, E. Day, M. Zafari, C. Benjamin, et al.
Comparison of Soluble Decoy IgG Fusion Proteins of BAFF-R and BCMA as Antagonists for BAFF
J. Biol. Chem., August 29, 2003; 278(35): 33127 - 33133.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. A. Vora, L. C. Wang, S. P. Rao, Z.-Y. Liu, G. R. Majeau, A. H. Cutler, P. S. Hochman, M. L. Scott, and S. L. Kalled
Cutting Edge: Germinal Centers Formed in the Absence of B Cell-Activating Factor Belonging to the TNF Family Exhibit Impaired Maturation and Function
J. Immunol., July 15, 2003; 171(2): 547 - 551.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Wu, L.-G. Xu, Z. Zhai, and H.-B. Shu
SINK Is a p65-interacting Negative Regulator of NF-{kappa}B-dependent Transcription
J. Biol. Chem., July 11, 2003; 278(29): 27072 - 27079.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
T. A. Phillips, J. Ni, and J. S. Hunt
Cell-specific expression of B lymphocyte (APRIL, BLyS)- and Th2 (CD30L/CD153)-promoting tumor necrosis factor superfamily ligands in human placentas
J. Leukoc. Biol., July 1, 2003; 74(1): 81 - 87.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. Craxton, D. Magaletti, E. J. Ryan, and E. A. Clark
Macrophage- and dendritic cell--dependent regulation of human B-cell proliferation requires the TNF family ligand BAFF
Blood, June 1, 2003; 101(11): 4464 - 4471.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
T. A. Riccobene, R. C. Miceli, C. Lincoln, Y. Knight, J. Meadows, M. G. Stabin, and C. Sung
Rapid and Specific Targeting of 125I-Labeled B Lymphocyte Stimulator to Lymphoid Tissues and B Cell Tumors in Mice
J. Nucl. Med., March 1, 2003; 44(3): 422 - 433.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
D. J. Buchsbaum and A. F. LoBuglio
Targeting of 125I-Labeled B Lymphocyte Stimulator
J. Nucl. Med., March 1, 2003; 44(3): 434 - 436.
[Full Text] [PDF]

Home page
 J. Exp. Med.Home page
C. S. Schmidt, J. Liu, T. Zhang, H. Y. Song, G. Sandusky, K. Mintze, R. J. Benschop, A. Glasebrook, D. D. Yang, and S. Na
Enhanced B Cell Expansion, Survival, and Humoral Responses by Targeting Death Receptor 6
J. Exp. Med., January 6, 2003; 197(1): 51 - 62.
[Abstract] [Full Text] [PDF]

Home page
 ASH Education BookHome page
M. J. Keating, N. Chiorazzi, B. Messmer, R. N. Damle, S. L. Allen, K. R. Rai, M. Ferrarini, and T. J. Kipps
Biology and Treatment of Chronic Lymphocytic Leukemia
Hematology, January 1, 2003; 2003(1): 153 - 175.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L.-G. Xu and H.-B. Shu
TNFR-Associated Factor-3 Is Associated With BAFF-R and Negatively Regulates BAFF-R-Mediated NF-{kappa}B Activation and IL-10 Production
J. Immunol., December 15, 2002; 169(12): 6883 - 6889.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
V. Roschke, S. Sosnovtseva, C. D. Ward, J. S. Hong, R. Smith, V. Albert, W. Stohl, K. P. Baker, S. Ullrich, B. Nardelli, et al.
BLyS and APRIL Form Biologically Active Heterotrimers That Are Expressed in Patients with Systemic Immune-Based Rheumatic Diseases
J. Immunol., October 15, 2002; 169(8): 4314 - 4321.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. J. Novak, R. J. Bram, N. E. Kay, and D. F. Jelinek
Aberrant expression of B-lymphocyte stimulator by B chronic lymphocytic leukemia cells: a mechanism for survival
Blood, September 26, 2002; 100(8): 2973 - 2979.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
L.-G. Xu, M. Wu, J. Hu, Z. Zhai, and H.-B. Shu
Identification of downstream genes up-regulated by the tumor necrosis factor family member TALL-1
J. Leukoc. Biol., August 1, 2002; 72(2): 410 - 416.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
B. Huard, P. Schneider, D. Mauri, J. Tschopp, and L. E. French
T Cell Costimulation by the TNF Ligand BAFF
J. Immunol., December 1, 2001; 167(11): 6225 - 6231.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
I. I. Kuzin, J. E. Snyder, G. D. Ugine, D. Wu, S. Lee, T. Bushnell Jr, R. A. Insel, F. M. Young, and A. Bottaro
Tetracyclines inhibit activated B cell function
Int. Immunol., July 1, 2001; 13(7): 921 - 931.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
S. Ishikawa, T. Sato, M. Abe, S. Nagai, N. Onai, H. Yoneyama, Y.-y. Zhang, T. Suzuki, S.-i. Hashimoto, T. Shirai, et al.
Aberrant High Expression of B Lymphocyte Chemokine (BLC/CXCL13) by C11b+CD11c+ Dendritic Cells in Murine Lupus and Preferential Chemotaxis of B1 Cells Towards BLC
J. Exp. Med., June 18, 2001; 193(12): 1393 - 1402.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
S. Xu and K.-P. Lam
B-Cell Maturation Protein, Which Binds the Tumor Necrosis Factor Family Members BAFF and APRIL, Is Dispensable for Humoral Immune Responses
Mol. Cell. Biol., June 15, 2001; 21(12): 4067 - 4074.
[Abstract] [Full Text]

Home page
 J. Pharmacol. Exp. Ther.Home page
T. J. Parry, T. A. Riccobene, S. J. Strawn, R. Williams, R. Daoud, J. Carrell, S. Sosnovtseva, R. C. Miceli, C. M. Poortman, L. Sekut, et al.
Pharmacokinetics and Immunological Effects of Exogenously Administered Recombinant Human B Lymphocyte Stimulator (BLyS) in Mice
J. Pharmacol. Exp. Ther., April 13, 2001; 296(2): 396 - 404.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
J. Zhang, V. Roschke, K. P. Baker, Z. Wang, G. S. Alarcon, B. J. Fessler, H. Bastian, R. P. Kimberly, and T. Zhou
Cutting Edge: A Role for B Lymphocyte Stimulator in Systemic Lupus Erythematosus
J. Immunol., January 1, 2001; 166(1): 6 - 10.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
B. Nardelli, O. Belvedere, V. Roschke, P. A. Moore, H. S. Olsen, T. S. Migone, S. Sosnovtseva, J. A. Carrell, P. Feng, J. G. Giri, et al.
Synthesis and release of B-lymphocyte stimulator from myeloid cells
Blood, January 1, 2001; 97(1): 198 - 204.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
C. F. Ware
APRIL and BAFF Connect Autoimmunity and Cancer
J. Exp. Med., December 4, 2000; 192(11): F35 - F38.
[Full Text] [PDF]

Home page
 J. Exp. Med.Home page
M. Batten, J. Groom, T. G. Cachero, F. Qian, P. Schneider, J. Tschopp, J. L. Browning, and F. Mackay
BAFF Mediates Survival of Peripheral Immature B Lymphocytes
J. Exp. Med., November 20, 2000; 192(10): 1453 - 1466.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
R. K.G. Do, E. Hatada, H. Lee, M. R. Tourigny, D. Hilbert, and S. Chen-Kiang
Attenuation of Apoptosis Underlies B Lymphocyte Stimulator Enhancement of Humoral Immune Response
J. Exp. Med., September 25, 2000; 192(7): 953 - 964.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
H.-B. Shu and H. Johnson
B cell maturation protein is a receptor for the tumor necrosis factor family member TALL-1
PNAS, July 19, 2000; (2000) 160213497.
[Abstract] [Full Text]

Home page
 J. Exp. Med.Home page
J. S. Thompson, P. Schneider, S. L. Kalled, L. Wang, E. A. Lefevre, T. G. Cachero, F. MacKay, S. A. Bixler, M. Zafari, Z.-Y. Liu, et al.
BAFF Binds to the Tumor Necrosis Factor Receptor-like Molecule B Cell Maturation Antigen and Is Important for Maintaining the Peripheral B Cell Population
J. Exp. Med., July 3, 2000; 192(1): 129 - 136.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page